Indonesian state-owned pharmaceutical company PT Kimia Farma Tbk (KAEF) is planning to invest Rp978 billion ($70.87 million) in a new pharmaceutical manufacturing facility at Banjaran Industrial Estate, Bandung, West Java. The new plant will cater to the growing domestic demand for herbal medicines.
The construction for the new plant is expected to begin in the current year and it is scheduled to be completed within two years.
